• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

围术期心脏风险分层的临床指标和生物标志物:更新。

Clinical indices and biomarkers for perioperative cardiac risk stratification: an update.

机构信息

Department of Anesthesiology and Intensive Care, School of Medicine, University of Niš, Niš, Serbia -

Center for Anesthesiology and Reanimatology, Clinical Center of Niš, Niš, Serbia -

出版信息

Minerva Anestesiol. 2017 Apr;83(4):392-401. doi: 10.23736/S0375-9393.16.11545-7. Epub 2016 Nov 30.

DOI:10.23736/S0375-9393.16.11545-7
PMID:27901331
Abstract

European Society of Cardiology (ESC)/ European Society of Anesthesiology (ESA) highlighted that anesthesiologist has a leading role in perioperative cardiovascular assessment and management in the year of 2014. During cardiovascular assessment one can rely on cooperation of multidisciplinary specialists like: other anesthesiologists, cardiologists and surgeons. For the purpose of precise systematization and decision making the Lee Score or NSQUIP database can be used besides the traditionally used ASA Score. Additional help is provided with specific palette of cardiac biomarkers like: cardiac troponins T, cardiac troponins I, C-reactive protein, N-terminal pro-brain natriuretic peptide, brain natriuretic peptide, etc. Biomarkers are considered to represent a foundation of evidence based medicine and they help anesthesiologists in the decision-making process. They increase the chance to achieve the best clinical outcome for each patient. An ideal biomarker does not exist and therefore new research are currently being conducted with the aim to find and declare more specific biomarkers like heart-type fatty acid-binding protein, micro RNA, PAMP and high sensitivity troponins T.

摘要

欧洲心脏病学会(ESC)/欧洲麻醉学会(ESA)强调,麻醉师在 2014 年的围手术期心血管评估和管理中发挥着主导作用。在心血管评估过程中,可以依靠多学科专家的合作,如其他麻醉师、心脏病专家和外科医生。为了进行精确的系统化和决策,可以使用 Lee 评分或 NSQUIP 数据库,除了传统使用的 ASA 评分。还可以使用特定的心脏生物标志物谱,如心脏肌钙蛋白 T、心脏肌钙蛋白 I、C 反应蛋白、N 端脑利钠肽前体、脑利钠肽等,提供额外的帮助。生物标志物被认为是循证医学的基础,它们有助于麻醉师在决策过程中做出决策。它们增加了为每位患者获得最佳临床结果的机会。目前正在进行新的研究,以寻找和宣布更具特异性的生物标志物,如心脏型脂肪酸结合蛋白、microRNA、PAMP 和高敏肌钙蛋白 T,理想的生物标志物并不存在。

相似文献

1
Clinical indices and biomarkers for perioperative cardiac risk stratification: an update.围术期心脏风险分层的临床指标和生物标志物:更新。
Minerva Anestesiol. 2017 Apr;83(4):392-401. doi: 10.23736/S0375-9393.16.11545-7. Epub 2016 Nov 30.
2
Cardiac biomarkers and risk assessment in patients undergoing major non-cardiac surgery: time to revise the guidelines?非心脏大手术患者的心脏生物标志物与风险评估:是时候修订指南了吗?
Clin Chem Lab Med. 2014 Jul;52(7):959-63. doi: 10.1515/cclm-2013-0900.
3
Revised ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management. Implications for preoperative clinical evaluation.欧洲心脏病学会/欧洲麻醉学会非心脏手术指南修订版:心血管评估与管理。对术前临床评估的影响。
Minerva Anestesiol. 2015 Feb;81(2):226-33. Epub 2014 Nov 11.
4
2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA).2014年欧洲心脏病学会/欧洲麻醉学会非心脏手术心血管评估和管理指南:非心脏手术心血管评估和管理联合工作组,由欧洲心脏病学会(ESC)和欧洲麻醉学会(ESA)组成。
Eur Heart J. 2014 Sep 14;35(35):2383-431. doi: 10.1093/eurheartj/ehu282. Epub 2014 Aug 1.
5
[Cardiovascular assessment and management prior to non-cardiac surgery. Comment on the new 2014 ESC/ESA guidelines].[非心脏手术前的心血管评估与管理。对2014年欧洲心脏病学会/欧洲麻醉学会新指南的评论]
Herz. 2015 Dec;40(8):1043-7. doi: 10.1007/s00059-015-4377-1.
6
Society of Cardiovascular Anesthesiologists/European Association of Cardiothoracic Anaesthetists Practice Advisory for the Management of Perioperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery.心血管麻醉医师协会/欧洲心胸麻醉医师协会关于心脏手术患者围手术期心房颤动管理的实践指南
J Cardiothorac Vasc Anesth. 2019 Jan;33(1):12-26. doi: 10.1053/j.jvca.2018.09.039.
7
N-terminal pro B type natriuretic peptide in high cardiovascular-risk patients for noncardiac surgery: What is the current prognostic evidence?非心脏手术高心血管风险患者的N末端前B型利钠肽:当前的预后证据是什么?
Ann Card Anaesth. 2016 Apr-Jun;19(2):314-20. doi: 10.4103/0971-9784.179636.
8
Perioperative cardiovascular evaluation: heads or tails?围手术期心血管评估:正面还是反面?
Rev Assoc Med Bras (1992). 2012 Jul-Aug;58(4):505-12.
9
2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA).2014年欧洲心脏病学会/欧洲麻醉学会非心脏手术心血管评估和管理指南:非心脏手术心血管评估和管理联合工作组:欧洲心脏病学会(ESC)和欧洲麻醉学会(ESA)
Eur J Anaesthesiol. 2014 Oct;31(10):517-73. doi: 10.1097/EJA.0000000000000150.
10
[PERIOPERATIVE MANAGEMENT IN PATIENTS WITH DISEASES OF THE CARDIOVASGULAR Yb I am IN NON-CARDIAC SURGERY (Commentary on the new European guidelines "Non-cardiac surgery: evaluation and management of cardiovascular system")].[非心脏手术患者心血管疾病的围手术期管理(对欧洲新指南“非心脏手术:心血管系统评估与管理”的评论)] (原文中“Yb I am”表述有误,推测可能是多余内容或有误,翻译时按正确理解处理)
Anesteziol Reanimatol. 2015 May-Jun;60(3):29-34.

引用本文的文献

1
Systematic preoperative approach for bariatric surgery, perioperative results, and economic impact.系统的减重手术术前方法、围手术期结果和经济影响。
Front Public Health. 2024 Oct 9;12:1439948. doi: 10.3389/fpubh.2024.1439948. eCollection 2024.
2
PROCALCITONIN GUIDED ANTIBIOTIC STEWARDSHIP: A BALKAN EXPERT CONSENSUS STATEMENT.降钙素原指导抗生素管理:巴尔干专家共识声明。
Acta Clin Croat. 2023 Apr;62(1):36-44. doi: 10.20471/acc.2023.62.01.05.
3
Usefulness of Preoperative Determination of Serum MR-ProAdrenomedullin Levels to Predict the Need for Postoperative Organ Support in Abdominal Oncological Surgery.
术前测定血清 MR-前肾上腺髓质素水平对预测腹部肿瘤手术术后器官支持需求的效用
J Pers Med. 2023 Jul 18;13(7):1151. doi: 10.3390/jpm13071151.
4
Biomarkers as Prognostic Predictors and Therapeutic Guide in Critically Ill Patients: Clinical Evidence.生物标志物作为危重症患者的预后预测指标和治疗指南:临床证据
J Pers Med. 2023 Feb 15;13(2):333. doi: 10.3390/jpm13020333.
5
Addition of clinical risk scores improves prediction performance of American Society of Anesthesiologists (ASA) physical status classification for postoperative mortality in older patients: a pilot study.临床风险评分的加入可提高美国麻醉医师协会(ASA)身体状况分类对老年患者术后死亡率的预测性能:一项试点研究。
Eur Geriatr Med. 2018 Feb;9(1):51-59. doi: 10.1007/s41999-017-0002-6. Epub 2017 Dec 21.
6
Clinical Utility of Survivin (BIRC5), Novel Cardiac Biomarker, as a Prognostic Tool Compared to High-sensitivity C-reactive Protein, Heart-type Fatty Acid Binding Protein and Revised Lee Score in Elderly Patients Scheduled for Major Non-cardiac Surgery: A Prospective Pilot Study.与高敏C反应蛋白、心脏型脂肪酸结合蛋白及修订版李氏评分相比,新型心脏生物标志物生存素(BIRC5)作为老年非心脏大手术患者预后评估工具的临床效用:一项前瞻性初步研究。
J Med Biochem. 2018 Apr 1;37(2):110-120. doi: 10.1515/jomb-2017-0046. eCollection 2018 Apr.